XML 32 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Apr. 30, 2012
Apr. 30, 2011
Current Assets    
Cash and cash equivalents $ 6,188 $ 2,402
Restricted cash 704 553
Receivables, less allowance: $311 (2012); $250 (2011) 23,244 27,346
Inventories 11,760 10,466
Deferred income taxes 713 431
Prepaid expenses and other current assets 989 1,181
Total Current Assets 43,598 42,379
Property, Plant and Equipment, Net 15,346 16,575
Other Assets    
Deferred income taxes 1,656 399
Other 3,536 3,705
Total Other Assets 5,192 4,104
Total Assets 64,136 63,058
Current Liabilities    
Short-term borrowings 6,816 6,588
Current obligations under capital leases 36 83
Current portion of long-term debt 200 200
Accounts payable 8,848 9,770
Employee compensation and amounts withheld 1,304 1,435
Deferred revenue 1,362 1,108
Other accrued expenses 1,674 1,080
Total Current Liabilities 20,240 20,264
Obligations under capital leases   36
Long-term debt 3,467 3,667
Accrued employee benefit plan costs 8,771 6,075
Total Liabilities 32,478 30,042
Commitments and Contingencies (Note 7)      
Stockholders' Equity    
Common stock, $2.50 par value, Authorized - 5,000 shares; Issued - 2,620 shares; Outstanding 2,579 shares (2012); 2,578 shares (2011) 6,550 6,550
Additional paid-in-capital 1,341 1,091
Retained earnings 29,218 29,218
Accumulated other comprehensive loss (7,176) (4,930)
Common stock in treasury, at cost: 40 shares (2012); 42 shares (2011) (422) (438)
Total Kewaunee Scientific Corporation Stockholders' Equity 29,511 31,491
Noncontrolling Interest 2,147 1,525
Total Equity 31,658 33,016
Total Liabilities and Stockholders' Equity $ 64,136 $ 63,058